Fibromyalgia

Researchers found that UV exposure resulted in greater positive affect, well-being, relaxation, and reduced pain levels when compared to non-UV exposure.

Among the numerous posters on display under the "Fibromyalgia and Soft Tissue Disorders" heading on day 4 at the American College of Rheumatology/Association of Rheumatology Health Professionals 2009 Annual Scientific Sessions were posters focused on the development of a fibromyalgia (FM) responder index, anxiety and depression among patients with FM, tai chi as an effective treatment of FM, and sex differences in predictors of increased symptoms after exercise and sleep restriction in patients with such chronic pain disorders as fibromyalgia.

Dozens of posters were presented under the "Fibromyalgia and Soft Tissue Disorders" umbrella during the morning of day 4 at the American College of Rheumatology/Association of Rheumatology Health Professionals 2009 Annual Scientific Sessions. Among the highlights are the following.

The 2009 American College of Rheumatology/Association of Rheumatology Health Professionals Scientific Meeting will feature several “Curbside Consult/Ask the Professors” sessions. Designed to feature information and discussion about “difficult management decisions that must be made in the absence of strong data,” these sessions give attendees the opportunity to “compare their personal management approaches” to the clinical problems outlined in the featured vignettes and scenarios with those of “the academic expert consultants and other clinicians in the audience.”

A new study finds that pindolol is highly effective for the treatment of fibromyalgia symptoms manifesting themselves through the autonomic nervous system.

Despite findings from other studies indicating that somnolence is a sometimes significant adverse effect in pregabalin use, this study suggests that it is statistically insignificant.

Fibromyalgia syndrome (FMS) is characterized by widespread chronic pain and tenderness. Persons with FMS are a diverse population, with widely variable symptom presentation and severity, as well as secondary symptoms. Because the symptoms are so diverse, diagnosis and management become challenging. Mounting evidence supports altered CNS processing of nociceptive stimuli as a mechanism.

The severity scores of dyspepsia symptoms and dyspepsia-related quality of life disturbance are higher in patients with fibromyalgia syndrome (FMS) than in patients with rheumatoid arthritis (RA) and in healthy persons.

The main predictor of adherence to a multimodal treatment program for patients with fibromyalgia syndrome (FMS) is barriers, such as lack of time, too much effort, stressful events, and fatigue. Because barriers are important for adherence and adherence is related to outcomes, using a questionnaire about barriers is recommended as a basis for discussing them with patients.

Molecular imaging reveals fibromyalgia symptoms related to functional brain abnormalities.